InvestorsHub Logo
Followers 52
Posts 5602
Boards Moderated 0
Alias Born 02/05/2016

Re: WojD40 post# 513831

Wednesday, 09/14/2022 2:46:31 PM

Wednesday, September 14, 2022 2:46:31 PM

Post# of 730806

Would love to hear some counterarguments to this.



The main issue I have is this:

If we were to be purchased at a premium, the Buyer might want to keep all the media powder dry and have their name - rather than NWBO's - associated with the DCVax breakthrough.



Because NWBO's share price is going to dictate a maximum that a company can pay. I don't care how monumental DCVax-L is, Merck's shareholders won't let them pay $10B (much less the crazy valuations people throw around here of $20+ billion) for a company that is trading at a value of less than $1B. Period. So in order for a large purchase to happen that NWBO shareholders will be happy with, the purchasing company will first have to work with NWBO to get the share price up. For which you will need those big media releases.

If we get an ASM proxy and there is no shelf increase then we've been bought, surely.


If that happens, I agree with the meaning. But I find this highly unlikely. They're going to increase the shelf to 2 billion, or flirt with an RS.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News